Literature DB >> 17054440

Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin.

David M Donovan1, Michelle Lardeo, Juli Foster-Frey.   

Abstract

The Staphylococcus aureus bacteriophage phi11 endolysin has two peptidoglycan hydrolase domains (endopeptidase and amidase) and an SH3b cell wall-binding domain. In turbidity reduction assays, the purified protein can lyse untreated staphylococcal mastitis pathogens, Staphylococcus aureus and coagulase-negative staphylococci (Staphylococcus chronogenes, Staphylococcus epidermidis, Staphylococcus hyicus, Staphylococcus simulans, Staphylococcus warneri and Staphylococcus xylosus), making it a strong candidate protein antimicrobial. This lytic activity is maintained at the pH (6.7), and the "free" calcium concentration (3 mM) of milk. Truncated endolysin-derived proteins containing only the endopeptidase domain also lyse staphylococci in the absence of the SH3b-binding domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17054440     DOI: 10.1111/j.1574-6968.2006.00483.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  47 in total

1.  Staphylococcal phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site.

Authors:  Igor Abaev; Juli Foster-Frey; Olga Korobova; Nina Shishkova; Natalia Kiseleva; Pavel Kopylov; Sergey Pryamchuk; Mathias Schmelcher; Stephen C Becker; David M Donovan
Journal:  Appl Microbiol Biotechnol       Date:  2012-07-10       Impact factor: 4.813

2.  Transducing particles of Staphylococcus aureus pathogenicity island SaPI1 are comprised of helper phage-encoded proteins.

Authors:  Sandra M Tallent; Timothy B Langston; Richard G Moran; Gail E Christie
Journal:  J Bacteriol       Date:  2007-08-10       Impact factor: 3.490

3.  Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci.

Authors:  Marianne Horgan; Gary O'Flynn; Jennifer Garry; Jakki Cooney; Aidan Coffey; Gerald F Fitzgerald; R Paul Ross; Olivia McAuliffe
Journal:  Appl Environ Microbiol       Date:  2008-12-01       Impact factor: 4.792

4.  Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.

Authors:  Lieh Yoon Low; Chen Yang; Marta Perego; Andrei Osterman; Robert Liddington
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

Review 5.  Recombinant bacteriophage lysins as antibacterials.

Authors:  Mark Fenton; Paul Ross; Olivia McAuliffe; Jim O'Mahony; Aidan Coffey
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

6.  Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK.

Authors:  Soo Youn Jun; Gi Mo Jung; Jee-Soo Son; Seong Jun Yoon; Yun-Jaie Choi; Sang Hyeon Kang
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

7.  X-ray crystal structure of the streptococcal specific phage lysin PlyC.

Authors:  Sheena McGowan; Ashley M Buckle; Michael S Mitchell; James T Hoopes; D Travis Gallagher; Ryan D Heselpoth; Yang Shen; Cyril F Reboul; Ruby H P Law; Vincent A Fischetti; James C Whisstock; Daniel C Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-17       Impact factor: 11.205

8.  A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.

Authors:  Rolf Lood; Assaf Raz; Henrik Molina; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

9.  Bacteriophage φEf11 ORF28 Endolysin, a Multifunctional Lytic Enzyme with Properties Distinct from All Other Identified Enterococcus faecalis Phage Endolysins.

Authors:  Hongming Zhang; Roy H Stevens; Bettina A Buttaro; Derrick E Fouts; Salar Sanjari; Bradley S Evans
Journal:  Appl Environ Microbiol       Date:  2019-06-17       Impact factor: 4.792

Review 10.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.